07/10/2025
7:50 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2025
7:56 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2025
3:27 PM | KalVista Pharmaceuticals (Filer)
| Form 424B5 | |
07/10/2025
6:13 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2025
7:39 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2025
6:27 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
6:28 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
6:28 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
10:44 AM | Capital World Investors (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/11/2025
4:22 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2025
6:30 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for KALV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/12/2025
3:31 PM | KalVista Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/10/2025
5:43 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:35 PM | KalVista Pharmaceuticals (Issuer)
Piekos Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:36 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:36 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:37 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:46 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:46 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:47 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
6:45 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
6:51 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:43 PM | KalVista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025
6:39 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/03/2025
6:42 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
3:57 PM | KalVista Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/16/2024
6:07 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
8:08 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:17 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:07 PM | KalVista Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/27/2024
7:43 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
7:45 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
3:41 PM | KalVista Pharmaceuticals (Issuer)
Reid Laurence (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
6:06 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
6:18 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
6:18 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
6:19 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
11:54 AM | Capital World Investors (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13G | |
11/12/2024
8:31 AM | Adage Capital Management, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/07/2024
1:34 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13D/A | |
11/04/2024
3:40 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The big winner of Crypto week? (Ad) It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption.
With Bitcoin hitting $123,000 and giants like BlackRock and Fidelity pouring in, one expert believes a lesser-known coin could soon be vaulted to the top — possibly even landing in the government’s digital reserve. See the coin positioned to win from Washington’s crypto push |
11/04/2024
11:00 AM | KalVista Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
6:00 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
3:05 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
3:06 PM | KalVista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:07 PM | KalVista Pharmaceuticals (Issuer)
Treanor Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:07 PM | KalVista Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:08 PM | KalVista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:08 PM | Fairey William (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:32 PM | KalVista Pharmaceuticals (Issuer)
Piekos Brian (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/11/2024
3:34 PM | KalVista Pharmaceuticals (Issuer)
Piekos Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
7:31 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:39 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:24 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:07 PM | KalVista Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/26/2024
6:58 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
7:00 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:13 PM | KalVista Pharmaceuticals (Filer)
| Form DEFA14A | |
08/22/2024
3:17 PM | KalVista Pharmaceuticals (Filer)
| Form ARS | |
08/22/2024
3:08 PM | KalVista Pharmaceuticals (Filer)
| Form DEF 14A | |
08/21/2024
8:25 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
8:25 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
8:26 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:23 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2024
11:15 PM | KalVista Pharmaceuticals (Filer)
| Form EFFECT | |
Free KALV Stock Alerts